Constantly evolving biopharmaceutical pipelines require continuous evolution of CHO-based bioproduction platforms for discovery, development and commercial applications. Cell lines must more efficiently and consistently deliver high yields of diverse and increasingly complex products with improved product quality in reduced timelines at lower costs. There is consequently a need to develop new expression tools and bioproduction processes and repurpose and reoptimize existing ones.
This eBook presents some of the solutions developed by Lonza to address the protein expression challenges of today and the future.